BBI-4000

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
25
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hyperhidrosis

Conditions

Hyperhidrosis

Trial Timeline

Feb 1, 2014 โ†’ Sep 1, 2014

About BBI-4000

BBI-4000 is a phase 1 stage product being developed by Botanix Pharmaceuticals for Hyperhidrosis. The current trial status is completed. This product is registered under clinical trial identifier NCT02058264. Target conditions include Hyperhidrosis.

Hype Score Breakdown

Clinical
10
Activity
5
Company
2
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT02058264Phase 1Completed